Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Herpes Zoster, a Rash of Cerebrovascular Events.

Nagel MA, Bubak AN.

Mayo Clin Proc. 2019 May;94(5):742-744. doi: 10.1016/j.mayocp.2019.03.020. No abstract available.

PMID:
31054599
2.

Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-L1 enhances virus-specific CD8+ T cell effector function.

Jones D, Como CN, Jing L, Blackmon A, Neff CP, Krueger O, Bubak AN, Palmer BE, Koelle DM, Nagel MA.

PLoS Pathog. 2019 Mar 14;15(3):e1007650. doi: 10.1371/journal.ppat.1007650. eCollection 2019 Mar.

3.

Varicella Zoster Virus Alters Expression of Cell Adhesion Proteins in Human Perineurial Cells Via Interleukin 6.

Blackmon AM, Como CN, Bubak AN, Mescher T, Jones D, Nagel MA.

J Infect Dis. 2019 Mar 5. pii: jiz095. doi: 10.1093/infdis/jiz095. [Epub ahead of print]

PMID:
30835269
4.

Varicella Zoster Virus Induces Differential Cell-Type Specific Responses in Human Corneal Epithelial Cells and Keratocytes.

Como CN, Bubak AN, Blackmon AM, Jones D, Mueller NH, Davidson R, Nagel MA.

Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):704-711. doi: 10.1167/iovs.18-25801.

5.

Varicella zoster virus differentially alters morphology and suppresses proinflammatory cytokines in primary human spinal cord and hippocampal astrocytes.

Bubak AN, Como CN, Blackmon AM, Jones D, Nagel MA.

J Neuroinflammation. 2018 Nov 15;15(1):318. doi: 10.1186/s12974-018-1360-9.

6.

Reactivation of Simian Varicella Virus in Rhesus Macaques after CD4 T Cell Depletion.

Traina-Dorge V, Palmer BE, Coleman C, Hunter M, Frieman A, Gilmore A, Altrock K, Doyle-Meyers L, Nagel MA, Mahalingam R.

J Virol. 2019 Jan 17;93(3). pii: e01375-18. doi: 10.1128/JVI.01375-18. Print 2019 Feb 1.

7.

Varicella Zoster Virus Vasculopathy.

Nagel MA, Bubak AN.

J Infect Dis. 2018 Sep 22;218(suppl_2):S107-S112. doi: 10.1093/infdis/jiy425.

PMID:
30247600
8.

Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.

Betker JL, Jones D, Childs CR, Helm KM, Terrell K, Nagel MA, Anchordoquy TJ.

J Control Release. 2018 Sep 28;286:85-93. doi: 10.1016/j.jconrel.2018.07.031. Epub 2018 Jul 17.

PMID:
30030182
9.

Varicella Zoster Virus Induces Nuclear Translocation of the Neurokinin-1 Receptor, Promoting Lamellipodia Formation and Viral Spread in Spinal Astrocytes.

Bubak AN, Como CN, Blackmon AM, Frietze S, Mescher T, Jones D, Cohrs RJ, Paucek P, Baird NL, Nagel MA.

J Infect Dis. 2018 Sep 8;218(8):1324-1335. doi: 10.1093/infdis/jiy297.

PMID:
29788447
10.

Attenuation of Simian Varicella Virus Infection by Enhanced Green Fluorescent Protein in Rhesus Macaques.

Mahalingam R, Kaufer BB, Ouwendijk WJD, Verjans GMGM, Coleman C, Hunter M, Das A, Palmer BE, Clambey E, Nagel MA, Traina-Dorge V.

J Virol. 2018 Mar 14;92(7). pii: e02253-17. doi: 10.1128/JVI.02253-17. Print 2018 Apr 1.

11.

Varicella zoster virus-infected cerebrovascular cells produce a proinflammatory environment.

Jones D, Neff CP, Palmer BE, Stenmark K, Nagel MA.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 13;4(5):e382. doi: 10.1212/NXI.0000000000000382. eCollection 2017 Sep.

12.

Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis.

Nagel MA, Jones D, Wyborny A.

J Neuroimmunol. 2017 Jul 15;308:112-117. doi: 10.1016/j.jneuroim.2017.03.014. Epub 2017 Mar 18. Review.

13.

Donald H. Gilden, M.D.

Owens GP, Nagel MA, Mahalingam R, Cohrs RJ.

J Neuroimmunol. 2017 Jul 15;308:2-5. doi: 10.1016/j.jneuroim.2017.01.002. Epub 2017 Jan 6. No abstract available.

PMID:
28087078
14.

Varicella-Zoster Virus Downregulates Programmed Death Ligand 1 and Major Histocompatibility Complex Class I in Human Brain Vascular Adventitial Fibroblasts, Perineurial Cells, and Lung Fibroblasts.

Jones D, Blackmon A, Neff CP, Palmer BE, Gilden D, Badani H, Nagel MA.

J Virol. 2016 Nov 14;90(23):10527-10534. doi: 10.1128/JVI.01546-16. Print 2016 Dec 1.

15.

Successful antiviral treatment after 6years of chronic progressive neurological disease attributed to VZV brain infection.

Gilden D, Grose C, White T, Nagae L, Hendricks RL, Cohrs RJ, Nagel MA.

J Neurol Sci. 2016 Sep 15;368:240-2. doi: 10.1016/j.jns.2016.07.035. Epub 2016 Jul 15.

16.

Burning mouth syndrome associated with varicella zoster virus.

Nagel MA, Gilden D.

BMJ Case Rep. 2016 Jul 5;2016. pii: bcr2016215953. doi: 10.1136/bcr-2016-215953.

17.

Proinflammatory cytokines and matrix metalloproteinases in CSF of patients with VZV vasculopathy.

Jones D, Alvarez E, Selva S, Gilden D, Nagel MA.

Neurol Neuroimmunol Neuroinflamm. 2016 Jun 13;3(4):e246. doi: 10.1212/NXI.0000000000000246. eCollection 2016 Aug.

18.

SUNCT headaches after ipsilateral ophthalmic-distribution zoster.

Nagel MA, Burns TM, Gilden D.

J Neurol Sci. 2016 Jul 15;366:207-208. doi: 10.1016/j.jns.2016.05.027. Epub 2016 May 14.

19.

Varicella zoster virus triggers the immunopathology of giant cell arteritis.

Gilden D, Nagel MA.

Curr Opin Rheumatol. 2016 Jul;28(4):376-82. doi: 10.1097/BOR.0000000000000292. Review.

20.

Blinded search for varicella zoster virus in giant cell arteritis (GCA)-positive and GCA-negative temporal arteries.

Gilden D, White T, Khmeleva N, Katz BJ, Nagel MA.

J Neurol Sci. 2016 May 15;364:141-3. doi: 10.1016/j.jns.2016.03.020. Epub 2016 Mar 19.

21.

Varicella Zoster Virus Infection in Granulomatous Arteritis of the Aorta.

Gilden D, White T, Boyer PJ, Galetta KM, Hedley-Whyte ET, Frank M, Holmes D, Nagel MA.

J Infect Dis. 2016 Jun 15;213(12):1866-71. doi: 10.1093/infdis/jiw101. Epub 2016 Mar 31.

22.

VZV in biopsy-positive and -negative giant cell arteritis: Analysis of 100+ temporal arteries.

Gilden D, White T, Khmeleva N, Boyer PJ, Nagel MA.

Neurol Neuroimmunol Neuroinflamm. 2016 Mar 9;3(2):e216. doi: 10.1212/NXI.0000000000000216. eCollection 2016 Apr. No abstract available.

23.

Varicella zoster virus and giant cell arteritis.

Gilden D, Nagel MA.

Curr Opin Infect Dis. 2016 Jun;29(3):275-9. doi: 10.1097/QCO.0000000000000258. Review.

24.

Frequency of varicella zoster virus DNA in human adrenal glands.

Badani H, White T, Schulick N, Raeburn CD, Topkaya I, Gilden D, Nagel MA.

J Neurovirol. 2016 Jun;22(3):400-2. doi: 10.1007/s13365-016-0425-8. Epub 2016 Feb 3.

25.

Developments in Varicella Zoster Virus Vasculopathy.

Nagel MA, Gilden D.

Curr Neurol Neurosci Rep. 2016 Feb;16(2):12. doi: 10.1007/s11910-015-0614-5. Review.

26.

Risk of Stroke and Myocardial Infarction After Herpes Zoster in Older Adults in a US Community Population.

Yawn BP, Wollan PC, Nagel MA, Gilden D.

Mayo Clin Proc. 2016 Jan;91(1):33-44. doi: 10.1016/j.mayocp.2015.09.015. Epub 2015 Dec 15.

27.

Varicella-Zoster Virus in Giant Cell Arteritis--Reply.

Nagel MA, White T, Gilden D.

JAMA Neurol. 2016 Feb;73(2):239. doi: 10.1001/jamaneurol.2015.3871. No abstract available.

PMID:
26659618
28.

Differential regulation of matrix metalloproteinases in varicella zoster virus-infected human brain vascular adventitial fibroblasts.

Nagel MA, Choe A, Rempel A, Wyborny A, Stenmark K, Gilden D.

J Neurol Sci. 2015 Nov 15;358(1-2):444-6. doi: 10.1016/j.jns.2015.09.349. Epub 2015 Sep 16.

29.

Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis.

Nagel MA, White T, Khmeleva N, Rempel A, Boyer PJ, Bennett JL, Haller A, Lear-Kaul K, Kandasmy B, Amato M, Wood E, Durairaj V, Fogt F, Tamhankar MA, Grossniklaus HE, Poppiti RJ, Bockelman B, Keyvani K, Pollak L, Mendlovic S, Fowkes M, Eberhart CG, Buttmann M, Toyka KV, Meyer-ter-Vehn T, Petursdottir V, Gilden D.

JAMA Neurol. 2015 Nov;72(11):1281-7. doi: 10.1001/jamaneurol.2015.2101.

30.

Successful Antiviral Treatment of Giant Cell Arteritis and Takayasu Arteritis.

Gilden D, White TM, Nagae L, Gurdin WH, Boyer PJ, Nagel MA.

JAMA Neurol. 2015 Aug;72(8):943-6. doi: 10.1001/jamaneurol.2015.0840. No abstract available.

31.

Widespread arterial infection by varicella-zoster virus explains refractory giant cell arteritis.

Gilden D, White T, Galetta SL, Fogt F, Nagel MA.

Neurol Neuroimmunol Neuroinflamm. 2015 Jun 4;2(4):e125. doi: 10.1212/NXI.0000000000000125. eCollection 2015 Aug. No abstract available.

32.

Varicella Zoster Virus in Ischemic Optic Neuropathy.

Golas L, Bennett JL, White TM, Skarf B, Lesser R, Nagel MA, Gilden D.

Ophthalmology. 2015 Oct;122(10):2142-5. doi: 10.1016/j.ophtha.2015.04.026. Epub 2015 Jun 6. No abstract available.

33.

Disseminated VZV infection and asymptomatic VZV vasculopathy after steroid abuse.

Nagel MA, Lenggenhager D, White T, Khmeleva N, Heintzman A, Boyer PJ, Gilden D.

J Clin Virol. 2015 May;66:72-5. doi: 10.1016/j.jcv.2015.03.016. Epub 2015 Mar 18.

34.

Burning mouth syndrome due to herpes simplex virus type 1.

Nagel MA, Choe A, Traktinskiy I, Gilden D.

BMJ Case Rep. 2015 Apr 1;2015. pii: bcr2015209488. doi: 10.1136/bcr-2015-209488.

35.

Varicella zoster virus pneumonitis and brainstem encephalitis without skin rash in an immunocompetent adult.

Nandhagopal R, Khmeleva N, Jayakrishnan B, White T, Al Azri F, George J, Heintzman A, Al Zeedy K, Rorke-Adams L, Gujjar AR, Schmid DS, Al-Asmi A, Nagel MA, Jacob PC, Gilden D.

Open Forum Infect Dis. 2014 Aug 6;1(2):ofu064. doi: 10.1093/ofid/ofu064. eCollection 2014 Sep.

36.

The relationship between herpes zoster and stroke.

Nagel MA, Gilden D.

Curr Neurol Neurosci Rep. 2015 Apr;15(4):16. doi: 10.1007/s11910-015-0534-4. Review.

37.

Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis.

Gilden D, White T, Khmeleva N, Heintzman A, Choe A, Boyer PJ, Grose C, Carpenter JE, Rempel A, Bos N, Kandasamy B, Lear-Kaul K, Holmes DB, Bennett JL, Cohrs RJ, Mahalingam R, Mandava N, Eberhart CG, Bockelman B, Poppiti RJ, Tamhankar MA, Fogt F, Amato M, Wood E, Durairaj V, Rasmussen S, Petursdottir V, Pollak L, Mendlovic S, Chatelain D, Keyvani K, Brueck W, Nagel MA.

Neurology. 2015 May 12;84(19):1948-55. doi: 10.1212/WNL.0000000000001409. Epub 2015 Feb 18.

38.

Inhibition of phosphorylated-STAT1 nuclear translocation and antiviral protein expression in human brain vascular adventitial fibroblasts infected with varicella-zoster virus.

Nagel MA, James SF, Traktinskiy I, Wyborny A, Choe A, Rempel A, Baird NL, Gilden D.

J Virol. 2014 Oct;88(19):11634-7. doi: 10.1128/JVI.01945-14. Epub 2014 Jul 23.

39.

Varicella-zoster.

Gilden D, Nagel MA, Cohrs RJ.

Handb Clin Neurol. 2014;123:265-83. doi: 10.1016/B978-0-444-53488-0.00012-2. Review. No abstract available.

40.

Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.

El Kasmi KC, Pugliese SC, Riddle SR, Poth JM, Anderson AL, Frid MG, Li M, Pullamsetti SS, Savai R, Nagel MA, Fini MA, Graham BB, Tuder RM, Friedman JE, Eltzschig HK, Sokol RJ, Stenmark KR.

J Immunol. 2014 Jul 15;193(2):597-609. doi: 10.4049/jimmunol.1303048. Epub 2014 Jun 13.

41.

Biopsy-negative, varicella zoster virus (VZV)-positive giant cell arteritis, zoster, VZV encephalitis and ischemic optic neuropathy, all in one.

Teodoro T, Nagel MA, Geraldes R, White T, Mahalingam R, Batista P, Wellish M, Pimentel J, Khmeleva N, Heintzman A, Albuquerque L, Boyer PJ, Choe A, Peralta R, Gilden D.

J Neurol Sci. 2014 Aug 15;343(1-2):195-7. doi: 10.1016/j.jns.2014.05.035. Epub 2014 May 27.

42.

Rapid development of 9 cerebral aneurysms in varicella-zoster virus vasculopathy.

Liberman AL, Nagel MA, Hurley MC, Caprio FZ, Bernstein RA, Gilden D.

Neurology. 2014 Jun 10;82(23):2139-41. doi: 10.1212/WNL.0000000000000503. Epub 2014 May 14. No abstract available.

43.

Update on varicella zoster virus vasculopathy.

Nagel MA, Gilden D.

Curr Infect Dis Rep. 2014 Jun;16(6):407. doi: 10.1007/s11908-014-0407-z.

44.

Neurological complications of varicella zoster virus reactivation.

Nagel MA, Gilden D.

Curr Opin Neurol. 2014 Jun;27(3):356-60. doi: 10.1097/WCO.0000000000000092. Review.

45.

Frequency and abundance of alphaherpesvirus DNA in human thoracic sympathetic ganglia.

Nagel MA, Rempel A, Huntington J, Kim F, Choe A, Gilden D.

J Virol. 2014 Jul;88(14):8189-92. doi: 10.1128/JVI.01070-14. Epub 2014 Apr 30.

46.

Varicella zoster virus (VZV) in cerebral arteries of subjects at high risk for VZV reactivation.

Nagel MA, Khmeleva N, Choe A, Gutierrez J, Gilden D.

J Neurol Sci. 2014 Apr 15;339(1-2):32-4. doi: 10.1016/j.jns.2014.01.044. Epub 2014 Feb 8.

47.

Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency.

Sabry A, Hauk PJ, Jing H, Su HC, Stence NV, Mirsky DM, Nagel MA, Abbott JK, Dragone LL, Armstrong-Wells J, Curtis DJ, Cohrs R, Schmid DS, Gilden D, Gelfand EW.

J Allergy Clin Immunol. 2014 Apr;133(4):1225-1227. doi: 10.1016/j.jaci.2013.11.031. Epub 2014 Jan 11. No abstract available.

48.

Varicella-zoster virus trigeminal ganglioneuritis without rash.

Birlea M, Nagel MA, Khmeleva N, Choe A, Kleinschmidt-Demasters B, Hevner R, Boyer P, Lear-Kaul KC, Bos N, Wellish M, Cohrs RJ, Gilden D.

Neurology. 2014 Jan 7;82(1):90-2. doi: 10.1212/01.wnl.0000438228.48470.86. Epub 2013 Nov 27. No abstract available.

49.

Varicella zoster virus in the temporal artery of a patient with giant cell arteritis.

Nagel MA, Khmeleva N, Boyer PJ, Choe A, Bert R, Gilden D.

J Neurol Sci. 2013 Dec 15;335(1-2):228-30. doi: 10.1016/j.jns.2013.09.034. Epub 2013 Oct 2.

50.

Varicella zoster virus vasculopathy: clinical features and pathogenesis.

Nagel MA.

J Neurovirol. 2014 Apr;20(2):157-63. doi: 10.1007/s13365-013-0183-9. Epub 2013 Aug 6. Review.

Supplemental Content

Loading ...
Support Center